Dr. Atul Gogia is a consultant for internal medicine based in New Delhi. He has an expertise in the evaluation and treatment of infectious diseases and diabetes management. With years of clinical experience Dr. Atul is commonly consulted for all adult illnesses and ailments including chronic diseases which require expert care and attention. After his MBBS he obtained his DNB in internal medicine and underwent training in the UK to obtain membership of the prestigious Royal College of Physicians. Dr. Atul Gogia has made numerous publications throughout his career and is affiliated with various organizations related to his field of work.

Awards/Fellowship/Membership:

• Srimati Meena Dhamija award for best platform research paper 2014 awarded for “Resurfacing of Scrub Typhus” awarded by Delhi State Chapter Association of Physicians of India.
• Srimati Meena Dhamija award for best platform research paper 2015 awarded for “Mucormycosis” awarded by Delhi State Chapter Association of Physicians of India
• Membership Royal College of Physicians (UK)
• Member International AIDS Society (IAS)

Educational Grants:

• Grant from DRDO for research on Secondary Pulmonary Hypertension

Research Undertaken (last 5 years only)

• I am involved with many clinical drug trials for which I am the principle investigator. These trials are on Influenza, Rabies and HIV /AIDS, Rheumatoid Arthritis, Osteoporosis and Amyloidosis

Clinical Research

• A Phase IIIB, Multicenter, Randomized, Double blinded, placebo-controlled, Clinical efficacy study of BALOXAVIR MARBOXIL for the reduction of direct transmission of Influenza from otherwise healthy patients to household contacts
• Exploring novel biomarkers in Indian Pulmonary Arterial Hypertension patients through transcriptomic approach. Project funded by DRDO
• A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized Subjects With Influenza A Infection Who Are at Risk of Developing Complication.
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
• A clinical trial protocol for evaluation of immunogenicity and safety of Rabies vaccine human (cell culture) I.P in post exposure subjects.
• International randomized double blind, placebo-control, and phase 3 study of the efficacy and safety of KIACTA in preventing renal function decline in patients with AA Amyloidosis. Protocol No. M122835).
• A double blind, placebo controlled clinical trial to evaluate the efficacy and safety of Interferon Alpha-N3 therapy in addition to standard of care in adults hospitalized due to acute severe influenza. CRO Max Neemal Medical International Ltd. (Phase II).
• A phase 3, multicenter, randomized, double blind, controlled study to evaluate the efficacy and safety of Peramivir administered intravenously in addition to standard of care compared to standard of care alone in adults and adolescents who are hospitalized due to serious influenza.

Postgraduate Thesis Research

• Guide and Co-Guide for more than 15 Thesis